SCHEMBL7302605

SCHEMBL7302605

COc1ccc(SC(CC2CCCC2)C(C(=O)O)C(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
EPHX2 P34913 2/20 0.41
CHRM2 P08172 1/20 0.38
CTSK P43235 1/20 0.38
CPB2 Q96IY4 1/20 0.38
POLB P06746 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPY5R Q15761 1/20 0.37
KLK7 P49862 2/20 0.37
LDHA P00338 1/20 0.37
CTSS P25774 2/20 0.37
HTT P42858 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7307517 0.87 ADAM17 (0.43) ALDH1A1EPHX2CHRM2CTSKMEN1
SCHEMBL7308312 0.84 ALDH1A1 (0.41) ALDH1A1EPHX2CHRM2CTSKCPB2
SCHEMBL7304794 0.77 EPHX2 (0.43) ALDH1A1EPHX2CHRM2CTSKPOLB
SCHEMBL2646192 0.71 EPHX2 (0.48) ALDH1A1EPHX2CPB2POLBKLK7
SCHEMBL7308194 0.71 MMP3 (0.53) ALDH1A1EPHX2CTSKKMT2AKLK7
SCHEMBL7300038 0.70 LDHA (0.45) ALDH1A1MEN1KMT2ALDHAHTT
SCHEMBL726401 0.69 LDHA (0.46) ALDH1A1MEN1KMT2ALDHANPC1
SCHEMBL7310255 0.68 EPHX2 (0.43) ALDH1A1EPHX2CTSKPOLBKMT2A
SCHEMBL7793120 0.68 EPHX2 (0.54) ALDH1A1EPHX2CPB2POLBKMT2A
SCHEMBL1867699 0.67 GCK (0.37) ALDH1A1EPHX2CHRM2CTSKPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed